Shanghai Zhongshan Hospital
Clinical trials sponsored by Shanghai Zhongshan Hospital, explained in plain language.
-
New combo therapy may let some esophageal cancer patients keep their esophagus
Disease control Recruiting nowThis study is for adults with a type of esophageal cancer (squamous cell carcinoma) that can potentially be removed with surgery. The goal is to see if giving a combination of immunotherapy (tislelizumab) and chemotherapy (carboplatin and nab-paclitaxel) before any procedure can …
Phase: PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:37 UTC
-
New study aims to solve the weight-loss rebound problem
Disease control Recruiting nowThis study looks at how to help people with obesity keep weight off after losing it with a high-dose weight-loss drug called Mazdutide. About 420 adults will try either a year of intensive lifestyle changes, a lower weekly dose of Mazdutide, or both. The goal is to find a safe an…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:34 UTC
-
New cocktail targets Hard-to-Treat liver cancer
Disease control Recruiting nowThis study tests a new combination of drugs for people with advanced intrahepatic cholangiocarcinoma, a type of liver cancer that cannot be removed by surgery. About 35 participants will receive an oral drug called chidamide along with standard chemotherapy and immunotherapy. The…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:33 UTC
-
New hope for rare cancer: Real-World drug study launches
Disease control Recruiting nowThis study is testing a drug called surufatinib in 350 adults with advanced neuroendocrine tumors, a rare type of cancer. The goal is to see how well the drug controls the disease and what side effects occur when used in regular medical practice. Participants take the drug daily …
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:33 UTC
-
New fluid may help sepsis patients during emergency surgery
Disease control Recruiting nowThis study looks at whether a fluid called balanced gelatin is better than the usual fluid for people with sepsis who need emergency abdominal surgery. Sepsis causes dangerous fluid loss, and this gelatin fluid might help keep blood pressure stable and protect organs. About 318 a…
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:32 UTC
-
New blood thinner may be safer for elderly heart patients
Disease control Recruiting nowThis study tests whether a drug called indobufen works better than aspirin in older adults (over 65) who have had a heart attack or unstable angina and received a stent. About 2,800 participants will take either indobufen plus ticagrelor or aspirin plus ticagrelor for one year. T…
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:32 UTC
-
New hope for bile duct cancer: immunotherapy plus chemotherapy trial opens
Disease control Recruiting nowThis study is testing whether adding immunotherapy drugs (anti-PD-1/PD-L1 antibodies) to standard chemotherapy (gemcitabine and cisplatin) can help people with advanced bile duct cancer that cannot be removed by surgery. The trial will include about 50 adults and will check for s…
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:32 UTC
-
Revolutionary In-Body CAR-T therapy targets stubborn Graves' disease
Disease control Recruiting nowThis early-phase study tests a new treatment called HN2301 for people with refractory Graves' disease, a thyroid condition that doesn't improve with standard medication. HN2301 works by turning the body's own immune cells into cancer-fighting-like cells inside the body to target …
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:25 UTC
-
New drug combo targets advanced liver cancer in early trial
Disease control Recruiting nowThis study tests a combination of two types of drugs (anti-PD-1/PD-L1 and anti-VEGF) in 50 adults with advanced liver cancer that cannot be surgically removed. The goal is to see if the combination is safe and can shrink or control tumors. Participants must have a life expectancy…
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:25 UTC
-
Heart attack patients get new hope: early drug may stop second attack
Disease control Recruiting nowThis study tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early during a hospital stay for a heart attack can reduce the risk of another heart attack, stroke, or death over the next year. About 1,500 adults who had a recent heart attack and have …
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 10, 2026 14:24 UTC
-
Immune cell therapy aims to halt type 1 diabetes progression
Disease control Recruiting nowThis early-phase study tests a new treatment for type 1 diabetes using specially engineered immune cells (CAR-T cells) that target and calm the immune attack on the pancreas. Nine adults with early-stage type 1 diabetes will receive the therapy and be monitored for safety, blood …
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Balloon vs stent: which is better for Rock-Hard heart arteries?
Disease control Recruiting nowThis study tests whether a drug-coated balloon works as well as a drug-eluting stent for people with severe calcium buildup in their heart arteries. After doctors first soften the calcium with special tools, participants are randomly assigned to receive either the balloon or the …
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Immune cell therapy could offer new hope for stubborn thyroid disease
Disease control Recruiting nowThis early-stage study tests a new treatment called RD06-05, made from donor immune cells, for people with Graves' disease that hasn't improved with standard care. The goal is to see if it can safely stop the immune system from attacking the thyroid, allowing patients to stop thy…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
Herbal extract from centella asiatica tested as new Weight-Loss aid
Disease control Recruiting nowThis study tests whether asiaticoside, a compound from the Centella asiatica plant, can help adults with overweight or obesity lose weight. About 30 participants will take asiaticoside tablets for 12 weeks. Researchers will measure changes in metabolic rate and body weight to see…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Asthma drug could shield hearts after major attack
Disease control Recruiting nowThis study tests whether montelukast, a common asthma medication, can reduce heart muscle damage and improve recovery in 512 adults who had a severe type of heart attack (anterior STEMI) and underwent emergency angioplasty. Participants receive montelukast or a placebo alongside …
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
New drug cocktail shows promise against tough esophageal cancer
Disease control Recruiting nowThis study tests whether giving a combination of three drugs (envafolimab, albumin-bound paclitaxel, and carboplatin) before surgery can help people with advanced esophageal cancer. The goal is to shrink or eliminate the tumor before the operation, improving the chances of comple…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New chemo cocktail aims to improve outcomes in advanced colorectal cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new chemotherapy combination (NALIRIFOX plus targeted therapy) works better than the standard FOLFOX plus targeted therapy for people with metastatic colorectal cancer that cannot be removed by surgery. The study includes 144 adults who have not…
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Could a simple painkiller prevent lung failure after emergency surgery?
Disease control Recruiting nowThis study looks at whether giving a continuous 24-hour intravenous infusion of lidocaine (a common local anesthetic) can lower the chance of serious lung complications after emergency abdominal surgery for an infection inside the belly. About 428 adults having emergency surgery …
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New combo attack on stomach cancer: drugs plus surgery may slow spread
Disease control Recruiting nowThis study tests whether adding surgery to a drug combination (immunotherapy plus chemotherapy, with or without targeted therapy) helps people with stomach cancer that has spread to a few other places. About 84 adults aged 18-79 will be randomly assigned to get either the drugs a…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Apr 24, 2026 16:06 UTC
-
New heart scan could spot hidden blockages after stenting
Diagnosis Recruiting nowThis study tests a new imaging tool called µQFR to see how well it can detect leftover blockages in side branches of heart arteries after a single stent is placed. About 290 adults with complex coronary artery disease will be enrolled. The goal is to see if µQFR can accurately me…
Sponsor: Shanghai Zhongshan Hospital • Aim: Diagnosis
Last updated May 06, 2026 16:15 UTC
-
Poop pills could soothe your gut: new IBS trial launches
Symptom relief Recruiting nowThis study tests whether fecal microbiota transplantation (FMT) can reduce symptoms of irritable bowel syndrome (IBS). About 102 adults with hard-to-treat IBS will receive FMT via oral capsules or a tube once a month for three months. Researchers will track symptom changes, quali…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Symptom relief
Last updated May 10, 2026 14:33 UTC
-
New oxygen method may prevent dangerous dips during stomach scope in obese patients
Symptom relief Recruiting nowThis study compares two ways of giving oxygen during a sedated stomach scope in people with visceral obesity (belly fat). The goal is to see if a high-flow nasal cannula works better than a standard face mask at preventing low oxygen levels. About 200 adults will take part, and r…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Symptom relief
Last updated Apr 26, 2026 19:35 UTC
-
Simple blood pressure check may spot hidden heart danger
Knowledge-focused Recruiting nowThis study looks at whether a non-invasive blood pressure monitor can accurately detect blockages in the heart's main pumping chamber in people with hypertrophic cardiomyopathy. Researchers will compare blood pressure readings with standard heart ultrasound measurements in 800 ad…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 10, 2026 14:36 UTC
-
ICU Delirium's lingering toll: new study tracks recovery hurdles
Knowledge-focused Recruiting nowThis observational study follows 189 adults who experienced delirium in the ICU to understand how it impacts their physical, mental, and cognitive recovery after moving to a regular hospital ward. Researchers will use questionnaires to track problems like memory loss, depression,…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 10, 2026 14:33 UTC
-
Heart plaque mystery: why do some patients worsen despite strong meds?
Knowledge-focused Recruiting nowThis study looks at people with coronary heart disease who are already on intensive cholesterol-lowering therapy. Even with strong treatment, some patients still have worsening artery plaque. The researchers want to understand if leftover cholesterol or inflammation is the cause.…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 10, 2026 14:24 UTC
-
Massive biobank aims to unlock secrets of deadly variceal bleeding
Knowledge-focused Recruiting nowThis study collects blood, tissue, and imaging data from 1,000 people with portal hypertension (high blood pressure in the liver) who have or had variceal bleeding. The goal is to create a large database of genetic, imaging, and other health information to help doctors predict an…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 08, 2026 12:00 UTC
-
New imaging tech could predict heart attacks in diabetics
Knowledge-focused Recruiting nowThis study is looking at 1,516 people with diabetes to see if a new imaging method can spot dangerous fatty plaques in heart arteries. Participants will get a special camera inside their arteries to measure plaque features. The goal is to find which plaques might cause future hea…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC
-
Key trial: which stomach cancer surgery offers better survival?
Knowledge-focused Recruiting nowThis study compares two types of surgery for people with advanced stomach cancer: laparoscopic (small incisions with a camera) and open (larger incision). About 1,018 participants will be randomly assigned to one of the two surgeries. The main goal is to see which approach leads …
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC
-
6,000 heart attack patients to be tracked in major hospital registry
Knowledge-focused Recruiting nowThis study is a registry that will follow 6,000 people who had a heart attack and received emergency angioplasty (a procedure to open blocked heart arteries) at Zhongshan Hospital in Shanghai. Researchers will collect information on patients' health, treatments, and outcomes duri…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:03 UTC
-
Researchers track clot clearance in cirrhosis patients
Knowledge-focused Recruiting nowThis study looks at people with cirrhosis (scarred liver) who also have blood clots in the main vein to the liver and enlarged veins in the stomach or esophagus. Researchers will track 1500 participants over time to see what factors help the clot dissolve. The goal is to better u…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC
-
High-Speed CT could spot dangerous heart plaques without surgery
Knowledge-focused Recruiting nowThis study will test a new, faster CT scanner to see if it can better detect risky plaques and measure blood flow in the heart arteries of 500 adults with known or suspected coronary artery disease. Researchers will compare the CT results with standard tests like angiography and …
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC
-
Can exercise rewire your cells? new study targets prediabetes
Knowledge-focused Recruiting nowThis study looks at how an 8-week exercise program affects metabolism in 40 overweight or obese adults with prediabetes. Researchers will measure changes in body fat, blood sugar, and other health markers, and use advanced cell analysis to understand the molecular changes. The go…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC